MedPath

Group Exercise in Cancer Patients Under Active Treatment: Feasibility Pilot Study.

Not Applicable
Not yet recruiting
Conditions
Neoplastic Disease
Registration Number
NCT06825429
Lead Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Brief Summary

The aim of this study to investigate the feasibility in hospital reality, of a group exercise program for oncology patients under active treatment and evaluate its impact on some outcomes considered relevant from both clinical and subjective point of view.

Detailed Description

The intervention will consist of EFG sessions lasting 45 minutes each, twice a week for 12 weeks to be carried out in the gym of the Rehabilitation Day Hospital.

Each 45-minute session includes an initial relaxation/stretching phase, simple aerobic exercises, muscle strengthening exercises, balance exercises, and will be led by a physiotherapist. The exercises proposed to the group with ECOG 2 will be less intense and of less difficulty with the aim of adapting the activity to patients with a lower performance status (see appendix 4.5, V2, 07/10/2024). The groups will consist of a minimum of five patients and a maximum of ten. Patients will also be stimulated to perform physical activity at home to a total of 150 minutes per week. Patients will be assessed at baseline (T0), at the end of the intervention (T1,12 weeks) and 6 months after the start of the intervention (T2).

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria
  • neoplastic tumor
  • age>= 18
  • prognosis> 12 months
  • ECOG <=2
  • Walking with/ without aids
  • clinically stable
  • signed informed consent
  • Patients with bone metastases with ECOG from 0-1 suitable results
Exclusion Criteria
  • sensory deficits who cannot perform physical exercise
  • cognitive impairment that compromises collaboration and questionnaire filling
  • patients with pathologies (e.g. neurological, psychiatric) that do not allow the obtaining of valid informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Frequencythrough study completion, an average of 2 years

The frequency of at least 70% of the exercise sessions foreseen by the programme.

adherence to the group exercise programmethrough study completion, an average of 2 years

overall adherence to the group exercise programme \> 40%

Secondary Outcome Measures
NameTimeMethod
QoLthrough study completion, an average of 2 years

Questionnaire in which patients have to describe quality of life during study treatment

tolerance to effortthrough study completion, an average of 2 years

The effect of the EFG program on mood tone and physical function

© Copyright 2025. All Rights Reserved by MedPath